Biktarvy, formally known as bictegravir, is a effective single-tablet treatment for controlling HIV infection. This medication combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to multiply within the body, remarkably lowering the viral quantity. For many individ